People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Manufacturing, Retailing, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lincoln Park Biosciences, LLC | — | Manufacturing | Pre-Seed | $400K | $3.0M | 2022 |
| Old Line Biosciences LLC | — | Retailing | Pre-Seed | $263K | $1.3M | 2022 |
| Cranbrook Biosciences, LLC | — | Biotech / Pharma | Pre-Seed | $200K | $4.5M | 2021 |
| Desert Mountain Biosciences, LLC | — | Biotech / Pharma | Pre-Seed | $200K | $4.5M | 2021 |
Marcus Mamolen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marcus Mamolen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Tessmar-Bell | 4 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.